CL icon

Colgate-Palmolive

85.96 USD
-0.80
0.92%
At close Feb 10, 4:00 PM EST
After hours
85.96
+0.00
0.00%
1 day
-0.92%
5 days
-1.13%
1 month
-0.46%
3 months
-6.52%
6 months
-15.13%
Year to date
-5.07%
1 year
2.87%
5 years
11.13%
10 years
23.79%
 

About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.

Employees: 34,000

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 10 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

142% more first-time investments, than exits

New positions opened: 184 | Existing positions closed: 76

5% more funds holding

Funds holding: 1,794 [Q2] → 1,877 (+83) [Q3]

3% more capital invested

Capital invested by funds: $66.9B [Q2] → $68.9B (+$2.04B) [Q3]

1% less call options, than puts

Call options by funds: $475M | Put options by funds: $479M

5% less repeat investments, than reductions

Existing positions increased: 647 | Existing positions reduced: 680

2.98% less ownership

Funds ownership: 84.05% [Q2] → 81.07% (-2.98%) [Q3]

10% less funds holding in top 10

Funds holding in top 10: 10 [Q2] → 9 (-1) [Q3]

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$83
3%
downside
Avg. target
$98
13%
upside
High target
$112
30%
upside

10 analyst ratings

positive
60%
neutral
30%
negative
10%
JP Morgan
Andrea Teixeira
35% 1-year accuracy
19 / 54 met price target
13%upside
$97
Overweight
Maintained
3 Feb 2025
UBS
Peter Grom
29% 1-year accuracy
6 / 21 met price target
16%upside
$100
Buy
Maintained
3 Feb 2025
Stifel
Mark Astrachan
45% 1-year accuracy
15 / 33 met price target
8%upside
$93
Hold
Maintained
3 Feb 2025
RBC Capital
Nik Modi
20% 1-year accuracy
8 / 40 met price target
14%upside
$98
Sector Perform
Maintained
3 Feb 2025
Raymond James
Olivia Tong
33% 1-year accuracy
4 / 12 met price target
22%upside
$105
Outperform
Reiterated
3 Feb 2025

Financial journalist opinion

Based on 30 articles about CL published over the past 30 days

Neutral
Business Wire
17 hours ago
Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children
CHICAGO--(BUSINESS WIRE)--The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. In 2025, nearly 1,100 GKAS events are schedule.
Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children
Neutral
Business Wire
3 days ago
Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and EVP, General Manager, India, Prabha Narasimhan, will present on Friday, February 21, 2025 at 8:00 am ET at the Consumer Analyst Group of New York Conference. Investors may access a live webcast of this presentation and the presentation slides on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made.
Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference
Neutral
Forbes
6 days ago
Should You Pick CL Stock At $87?
Colgate-Palmolive stock (NYSE: CL) recently reported its Q4 results, with revenues missing and earnings slightly ahead of the street estimates. The company reported revenue of $4.94 billion and adjusted earnings of $0.91 per share, compared to the consensus estimates of $4.99 billion and $0.89, respectively.
Should You Pick CL Stock At $87?
Negative
Benzinga
1 week ago
Colgate-Palmolive Analysts Slash Their Forecasts After Q4 Results
Colgate-Palmolive Company CL posted mixed results for the fourth quarter on Friday.
Colgate-Palmolive Analysts Slash Their Forecasts After Q4 Results
Negative
The Motley Fool
1 week ago
Why Colgate-Palmolive Stock Fell Today
Shares of Colgate-Palmolive (CL -4.61%) pulled back today after the household products giant missed the mark on the top line in its fourth-quarter earnings report and gave a weak outlook.
Why Colgate-Palmolive Stock Fell Today
Positive
Benzinga
1 week ago
Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating on the shares of Colgate-Palmolive Co CL with a price forecast of $106.
Colgate-Palmolive Remains One Of The Highest-Quality Names Despite Tough End-Market Backdrop: Goldman Sachs
Positive
Zacks Investment Research
1 week ago
Colgate Q4 Earnings Beat, Strong Volume and Pricing Drive Results
CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions. Improved gross margins aid EPS growth.
Colgate Q4 Earnings Beat, Strong Volume and Pricing Drive Results
Positive
Zacks Investment Research
1 week ago
PCE Inflation Increased In Line With Expectation
Today's pre-market activity is positive, with futures in the green across major indexes: the Dow is +110 points at this hour, with the S&P 500 +26 and the Nasdaq leading the way, +158 points. The small-cap Russell 2000 is +5.
PCE Inflation Increased In Line With Expectation
Negative
Investopedia
1 week ago
Colgate-Palmolive Stock Falls as Foreign Exchange Rates Hurt Sales, Outlook
Colgate-Palmolive (CL) shares fell 5% Friday after the household products company missed revenue forecasts and gave weak guidance as it was hurt by foreign exchange rates.
Colgate-Palmolive Stock Falls as Foreign Exchange Rates Hurt Sales, Outlook
Negative
Seeking Alpha
1 week ago
Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Toothpaste and manual toothbrushes market leader Colgate-Palmolive Company released its fourth quarter and full-year 2024 results today. Judging by the share price reaction, and considering CL stock is down more than 20% from its all-time high, this clearly looks like a “buy the dip” moment. However, I'll explain why I don't think it's a good idea to buy CL shares, either for dividend or total return investors, and despite the company's undoubtedly solid 2024 performance.
Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Charts implemented using Lightweight Charts™